Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TACR1 | P25103 | 1/20 | 0.40 |
| ▸ | DPP4 | P27487 | 14/20 | 0.38 |
| ▸ | DPP8 | Q6V1X1 | 6/20 | 0.38 |
| ▸ | DPP9 | Q86TI2 | 6/20 | 0.38 |
| ▸ | DPP7 | Q9UHL4 | 4/20 | 0.34 |
| ▸ | FAP | Q12884 | 2/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4595206 | 0.81 | DPP4 (0.44) | DPP4DPP8DPP9DPP7FAP | |
| SCHEMBL5734357 | 0.81 | DPP4 (0.44) | DPP4DPP8DPP9DPP7FAP | |
| SCHEMBL4595209 | 0.81 | DPP4 (0.44) | DPP4DPP8DPP9DPP7FAP | |
| SCHEMBL4440457 | 0.78 | ATM (0.39) | DPP4DPP8DPP9 | |
| SCHEMBL4440451 | 0.78 | ATM (0.39) | DPP4DPP8DPP9 | |
| SCHEMBL7831182 | 0.78 | DPP7 (0.41) | DPP4DPP8DPP9DPP7 | |
| SCHEMBL8200272 | 0.78 | DPP7 (0.41) | DPP4DPP8DPP9DPP7 | |
| SCHEMBL7759104 | 0.78 | DPP4 (0.42) | DPP4DPP8DPP9DPP7FAP | |
| SCHEMBL10454951 | 0.78 | TRHR (0.43) | DPP4DPP8DPP9 | |
| SCHEMBL7759091 | 0.78 | DPP4 (0.42) | DPP4DPP8DPP9DPP7FAP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070078096-A1 | Buffered drug formulations for transdermal electrotransport delivery | CORMIER MICHEL J | 2007-04-05 | — | — | US | claimed |
| US-20050171021-A1 | Buffered drug formulations for transdermal | CORMIER MICHEL J (US) | 2005-08-04 | — | — | US | claimed |
| EP-1028706-B1 | BUFFERED DRUG FORMULATIONS FOR TRANSDERMAL ELECTROTRANSPORT DELIVERY | ALZA CORP (US) | 2003-07-09 | — | — | EP | claimed |
| US-20020058608-A1 | BUFFERED DRUG FORMULATIONS FOR TRANSDERMAL ELECTROTRANSPORT DELIVERY | ALZA CORPORATION | 2002-05-16 | — | — | US | claimed |
| EP-1028706-A1 | BUFFERED DRUG FORMULATIONS FOR TRANSDERMAL ELECTROTRANSPORT DELIVERY | ALZA CORPORATION (US) | 2000-08-23 | — | — | EP | claimed |
| WO-1999024015-A1 | BUFFERED DRUG FORMULATIONS FOR TRANSDERMAL ELECTROTRANSPORT DELIVERY | ALZA CORPORATION (US) | 1999-05-20 | — | — | WO | claimed |
| EP-1689489-B1 | PEPTIDICALLY BUFFERED FORMULATIONS FOR ELECTROTRANSPORT APPLICATIONS AND METHODS OF MAKING | ALZA CORP (US) | 2008-02-27 | — | — | EP | disclosed |
| US-20070249988-A1 | Electrotransport Delivery of Nesiritide | ALZA CORPORATION (US) | 2007-10-25 | — | — | US | disclosed |
| US-20070078096-A1 | Buffered drug formulations for transdermal electrotransport delivery | CORMIER MICHEL J | 2007-04-05 | — | — | US | disclosed |
| EP-1689489-A1 | PEPTIDICALLY BUFFERED FORMULATIONS FOR ELECTROTRANSPORT APPLICATIONS AND METHODS OF MAKING | Alza Corporation (US) | 2006-08-16 | — | — | EP | disclosed |
| US-20050171021-A1 | Buffered drug formulations for transdermal | CORMIER MICHEL J (US) | 2005-08-04 | — | — | US | disclosed |
| US-20050142531-A1 | Peptidically buffered formulations for electrotransport applications and methods of making | ALZA CORPORATION | 2005-06-30 | — | — | US | disclosed |
| WO-2005051485-A1 | PEPTIDICALLY BUFFERED FORMULATIONS FOR ELECTROTRANSPORT APPLICATIONS AND METHODS OF MAKING | ALZA CORPORATION (US) | 2005-06-09 | — | — | WO | disclosed |
| EP-1028706-B1 | BUFFERED DRUG FORMULATIONS FOR TRANSDERMAL ELECTROTRANSPORT DELIVERY | ALZA CORP (US) | 2003-07-09 | — | — | EP | disclosed |
| US-20020058608-A1 | BUFFERED DRUG FORMULATIONS FOR TRANSDERMAL ELECTROTRANSPORT DELIVERY | ALZA CORPORATION | 2002-05-16 | — | — | US | disclosed |